NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,084 filers reported holding NOVARTIS A G in Q4 2018. The put-call ratio across all filers is 0.74 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $458,000 | -2.8% | 5,313 | -14.8% | 0.11% | -66.4% |
| Q2 2018 | $471,000 | -53.9% | 6,237 | -50.6% | 0.32% | +45.3% |
| Q1 2018 | $1,021,000 | -3.3% | 12,636 | +2.7% | 0.22% | +46.7% |
| Q3 2017 | $1,056,000 | +22.2% | 12,303 | +18.8% | 0.15% | +2.7% |
| Q2 2017 | $864,000 | +1316.4% | 10,352 | +1139.8% | 0.15% | +1245.5% |
| Q1 2017 | $61,000 | -49.2% | 835 | -49.6% | 0.01% | -47.6% |
| Q4 2016 | $120,000 | +14.3% | 1,656 | +21.0% | 0.02% | +5.0% |
| Q3 2016 | $105,000 | +2.9% | 1,369 | +10.9% | 0.02% | +11.1% |
| Q2 2016 | $102,000 | -20.3% | 1,234 | -27.0% | 0.02% | -21.7% |
| Q1 2016 | $128,000 | -7.2% | 1,691 | -5.8% | 0.02% | -4.2% |
| Q4 2015 | $138,000 | -11.5% | 1,796 | +3.8% | 0.02% | -17.2% |
| Q3 2015 | $156,000 | +420.0% | 1,731 | +477.0% | 0.03% | +480.0% |
| Q2 2015 | $30,000 | -85.2% | 300 | -85.4% | 0.01% | -85.7% |
| Q1 2015 | $203,000 | – | 2,061 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANAGED ASSET PORTFOLIOS, LLC | 332,962 | $27,452,000 | 7.32% |
| Mawer Investment Management Ltd. | 7,721,327 | $636,623,000 | 5.86% |
| Martin Investment Management, LLC | 133,246 | $10,986,000 | 5.56% |
| SCHARF INVESTMENTS, LLC | 1,330,175 | $109,673,000 | 5.48% |
| Hansberger Growth Investors, LP | 46,663 | $3,847,000 | 5.19% |
| Bain Capital Public Equity Management II, LLC | 440,233 | $36,297,000 | 4.25% |
| First Fiduciary Investment Counsel, Inc. | 187,633 | $15,470,000 | 4.10% |
| GARLAND CAPITAL MANAGEMENT INC | 53,555 | $4,416,000 | 4.02% |
| Lowell Blake & Associates Inc. | 37,219 | $3,069,000 | 3.94% |
| PRENTISS SMITH & CO INC | 68,027 | $5,609,000 | 3.89% |